Targeted Endoperoxides Delivering Singlet Oxygen to Cancer Cell Mitochondria: Exploration of the Therapeutic...

Area of Science:

• Biochemistry
• Oncology
• Nanotechnology

Background:

• Photodynamic therapy (PDT) for cancer is limited to superficial tumors due to the requirement for external light sources.
• Generating reactive oxygen species (ROS), specifically singlet oxygen, is crucial for PDT efficacy but faces challenges with light penetration and oxygen availability.

Purpose of the Study:

• To design and synthesize novel naphthalene-derived endoperoxides capable of releasing singlet oxygen via thermal cycloreversion.
• To evaluate the efficacy and safety of these compounds as a potential new modality for cancer treatment, independent of external light.

Main Methods:

• Synthesis of naphthalene-derived endoperoxides functionalized with mitochondria-targeting triphenylphosphonium moieties.
• In vitro assessment of singlet oxygen release and cancer cell death induction (IC50 determination).
• In vivo evaluation using a 4T1 breast tumor mouse model with intraperitoneal administration.

Main Results:

• The synthesized compounds effectively released singlet oxygen through thermal cycloreversion.
• Demonstrated potent cytotoxicity against cancer cell cultures with IC50 values below 10 μM.
• The 4T1 breast tumor model study showed promising tumor reduction with negligible systemic toxicity.

Conclusions:

• Mitochondria-targeted endoperoxides offer a light- and oxygen-independent approach to singlet oxygen generation for cancer therapy.
• This strategy represents a significant advancement, potentially broadening the applicability of photodynamic therapy for various cancer types.
• The developed compounds exhibit a promising therapeutic window, paving the way for new cancer treatment methodologies.